Delivery Order SPE2DB24D2205-SPE2DB25FEFGA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price contract. This non-set-aside award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,315.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by August 15, 2025. The award represents a single delivery order transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $9,034.57 under a firm fixed price contract type. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $1,837.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL vaccine syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract was performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a $28,321.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of July 30, 2025. This competitive, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,030.56 for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion deadline of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's broader federal contract portfolio supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,428.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $2,816.86 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 4,565,699,051 units of the ENGERIX-B 20 MCG/ML SYRNML vaccine. This delivery order was placed against an Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for providing pharmaceutical and medical supplies to support military...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFGADelivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that serves as the company's comprehensive global pharmaceutical support agreement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal medical procurement vendor through competitive awards with the Defense Logistics Agency and its Medical Supply Chain. The company's IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, brand-name and generic drugs, and medical devices to support military healthcare programs and other government healthcare systems. This ENGERIX-B vaccine delivery order exemplifies the company's role in fulfilling federal immunization and preventive healthcare requirements across military and defense-related medical supply networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 7/23/25 |